Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer - Wikidata - wikimedia - TriplyDB

Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer

Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer

http://www.wikidata.org/entity/Q34614989

about

Exosomal miRNAs as cancer biomarkers and therapeutic targets Extracellular MicroRNA in liquid biopsy: applicability in cancer diagnosis and prevention Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies Molecular Biomarkers in Bladder Cancer: Novel Potential Indicators of Prognosis and Treatment Outcomes Decoding the Secret of Cancer by Means of Extracellular Vesicles When Prostate Cancer Circulates in the Bloodstream Whole blood defensin mRNA expression is a predictive biomarker of docetaxel response in castration-resistant prostate cancer.Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers The functions and clinical applications of tumor-derived exosomes Suppression of endothelial cell migration by tumor associated macrophage-derived exosomes is reversed by epithelial ovarian cancer exosomal lncRNA Exosomes from the tumor microenvironment as reciprocal regulators that enhance prostate cancer progression.Gamma-glutamyltransferase activity in exosomes as a potential marker for prostate cancer MiR-21-5p in urinary extracellular vesicles is a novel biomarker of urothelial carcinoma.Circulating exosomal miR-125a-3p as a novel biomarker for early-stage colon cancer.MicroRNA in prostate cancer: functional importance and potential as circulating biomarkers.MicroRNA-375 plays a dual role in prostate carcinogenesis Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancer The emergence of extracellular vesicles in urology: fertility, cancer, biomarkers and targeted pharmacotherapy.Exosomes in cancer: small particle, big player.Global miRNA Expression Profiling Identifies miR-1290 as Novel Potential oncomiR in Laryngeal Carcinoma Meeting report: discussions and preliminary findings on extracellular RNA measurement methods from laboratories in the NIH Extracellular RNA Communication Consortium.A Panel of MicroRNAs as Diagnostic Biomarkers for the Identification of Prostate Cancer Plasma extracellular RNA profiles in healthy and cancer patients.Prostasomes as a source of diagnostic biomarkers for prostate cancer.Versatile roles of extracellular vesicles in cancer Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche.microRNA expression profiling on individual breast cancer patients identifies novel panel of circulating microRNA for early detection.miR-1207-3p Is a Novel Prognostic Biomarker of Prostate Cancer.MicroRNA expression and function in prostate cancer: a review of current knowledge and opportunities for discovery Common Genetic Variation in CYP17A1 and Response to Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer.Prostate-specific extracellular vesicles as a novel biomarker in human prostate cancer.Copy number variations in urine cell free DNA as biomarkers in advanced prostate cancer.miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1.Ago-RIP-Seq identifies Polycomb repressive complex I member CBX7 as a major target of miR-375 in prostate cancer progression.Increased Circulating Exosomal miRNA-223 Is Associated with Acute Ischemic Stroke.Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.Exosomes: From Garbage Bins to Promising Therapeutic Targets.Identification of prostate cancer biomarkers in urinary exosomes.Functional significance of aberrantly expressed microRNAs in prostate cancer.

P2860

Q26738660-4167A9DE-54A8-4F16-A1F9-5DC88E943114 Q26742027-61AB9748-38C0-479D-8EB5-B0FCB9D2E624 Q26748872-5AC5667A-6153-4DB8-9CC4-702CD03146EE Q26748881-D6ECD6B0-E527-4E31-A64D-46933E35E3FC Q26765922-DEE9F215-5F35-408C-920D-C68325565E2B Q26767179-44ED0100-EE7F-4852-B922-98332310A2C3 Q26768470-F7FC5BEB-C165-4725-867E-1BDD6819E4D7 Q27853196-A623C5FE-8B08-48DB-A747-DBE682709165 Q28075610-580445BC-51E0-4125-810A-20FEFD5F2372 Q30361738-5CB034D4-0941-4B1C-9562-928FE159215C Q30855032-98DE48E9-BF62-4465-A831-30095ADDB5EF Q33363486-00172513-83D8-49C7-99E7-272E47E4CFBF Q33644807-29E4B083-5D8A-4A3C-A016-0C31EB0BB7BC Q33648610-DAF99EA5-73F9-46EE-B937-3ACC4515593C Q33829967-597A18D4-E559-448D-8A4A-FD3A72A5C1C2 Q35510445-90455FE7-5C4C-4E12-8612-7409D4CF204C Q35606022-AF5C6ACF-7B7B-4B6C-8CAF-A5B951384B04 Q35615320-314156C6-C22C-4AC8-BDA2-D8D2EFD97947 Q35807725-8E26B3EF-51C6-4AE2-B271-B8511C3015F5 Q35834473-20CCEFE3-BFAE-4B21-8608-41ECCADB7F15 Q35875417-BE6CB135-F80B-4316-ADAB-3F81F9A59684 Q36006450-444363FE-CA60-4416-B2D0-E314BB3D0F7E Q36407203-DDAB3C47-C91E-40B3-AEDF-6EC34212CCFB Q36501082-7064C010-F953-486F-99F1-9C65BD696753 Q36737927-952D6F76-BA98-44A7-84E0-F26E6787EDEF Q36737955-1121F657-0C5B-4040-A388-23BF95330699 Q36782329-6B20DCDF-FEF3-4D31-8F8B-8417C312E7E4 Q36902655-2EC5B7D0-B76F-4F38-87A3-40F1AD0805E9 Q37004332-8957826F-3371-49D5-8289-0CA238FEF564 Q37113174-79BD9330-DC02-4DA2-80E3-1531D71D0B36 Q37134564-27813859-FB5E-42E8-82A9-BF8D322FAE2B Q37159960-111A3BDE-62A7-42B8-A886-AAA5775F40DC Q37392579-AD8F0A1C-2C37-4EFF-B611-076EE2FD0332 Q37408814-B7800532-40C0-4C20-AB4E-ACAE63A421AB Q37644574-893D551D-F96A-4782-9145-7127FE9E7B50 Q37667327-AF7ADA8F-6991-4325-918E-B328A1AED9C7 Q37706539-5F7FEDBC-76B8-46FB-B09A-8B79F7660270 Q37729108-FAC01C77-A56D-45A4-914C-04ECB2099FD3 Q38286457-D88777B6-30FA-4732-98D0-57DCF5675E8E Q38323461-212B9436-6E6B-4955-8CE4-DBF646B27C60

P2860

Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer

http://www.wikidata.org/entity/Q34614989

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Exosomal miR-1290 and miR-375 ...... tion-resistant prostate cancer

@ast

Exosomal miR-1290 and miR-375 ...... tion-resistant prostate cancer

@en

Exosomal miR-1290 and miR-375 ...... tion-resistant prostate cancer

@nl

type

label

Exosomal miR-1290 and miR-375 ...... tion-resistant prostate cancer

@ast

Exosomal miR-1290 and miR-375 ...... tion-resistant prostate cancer

@en

Exosomal miR-1290 and miR-375 ...... tion-resistant prostate cancer

@nl

prefLabel

Exosomal miR-1290 and miR-375 ...... tion-resistant prostate cancer

@ast

Exosomal miR-1290 and miR-375 ...... tion-resistant prostate cancer

@en

Exosomal miR-1290 and miR-375 ...... tion-resistant prostate cancer

@nl

P1433

Q34614989-5975D935-4A80-45DF-9035-B8F72B27C0AB

P1476

Q34614989-D8F7A5A4-D116-4BBE-ACBF-E00A3546F4F3

P2093

Q34614989-148C9C6F-5DD1-419D-9B2A-A3495D7E7245

Q34614989-23720F41-C551-4EC3-BCC1-9683EFFFD2A5

Q34614989-2B4D8423-C33E-4DC8-B7A6-8C0448B9A0D5

Q34614989-32EE7C20-27A3-405D-9591-38DE0F0745B3

Q34614989-34609B39-80A4-4871-A0E8-694EC762A90E

Q34614989-3FC6634C-3A17-4ED9-9C3D-B498437948FF

Q34614989-446878FA-1801-4323-9F64-5571657343C5

Q34614989-4726976E-BDA0-4F90-B09B-054434C68B9A

Q34614989-5ADE0445-708F-4038-9779-3CD5D45A6C67

Q34614989-7232B823-89A3-4190-B03A-55722A6B7FEA

P2860

Q34614989-04F04107-5990-476D-A0A8-2E8B0A26C7CA

Q34614989-05270E7B-4D6F-4974-850A-065E492E2869

Q34614989-2850C50F-C1CF-4101-B3A8-30BEC944977D

Q34614989-32643F4B-63E9-49B0-87CB-BD7708FB9C62

Q34614989-34A55DBB-4DE5-4DFB-B33E-8BA895A4E3BB

Q34614989-37BB2FC5-633E-437A-A855-B88AAD0DF7CB

Q34614989-45918C42-7A6C-40A5-A8D5-3AA1386B6A7A

Q34614989-48C8901E-3BF7-4285-AC64-E5CA60A731EE

Q34614989-51849B65-71A3-457B-9669-DC8D5A528764

Q34614989-54967817-E78F-4BA2-862D-320707AB09F7

P304

Q34614989-391B6FF0-E5DD-46CB-8E4F-BEDDAD47DC28

P31

Q34614989-C3B95E52-E552-4824-80C5-2445980F8B4C

P356

Q34614989-FC868D6A-A265-4C32-AF54-F108E85C73FE

P407

Q34614989-A063E227-39E2-49E2-95C0-5BD8889C97CE

P433

Q34614989-77586CC7-55E0-4E06-915B-4AB6F01B4A12

P478

Q34614989-7FDF394F-DF12-4240-A2BE-2A960EB1A51A

P50

Q34614989-0A566E5F-A038-4D87-85A5-418EF3E8179E

Q34614989-93DF7A0F-13F1-456C-9157-38091C877773

Q34614989-EF15F77E-1CBD-4694-A656-2D0B08065D09

P577

Q34614989-2DF7AAF6-7C0D-4133-959B-DB2578875AB4

P5875

Q34614989-E5847A51-E1C9-464E-9623-F7994F05EE10

P698

Q34614989-AF3FE76A-3230-4EF2-8C77-32B6E04E4F29

P932

Q34614989-3892D1C3-7637-456F-B653-B6D99EC27EBD

P356

J.EURURO.2014.07.035

P1433

European Urology

P1476

Exosomal miR-1290 and miR-375 ...... tion-resistant prostate cancer

@en

P2093

Brian A Costello

http://www.w3.org/2001/XMLSchema#string

Debashis Nandy

http://www.w3.org/2001/XMLSchema#string

Dian Wang

http://www.w3.org/2001/XMLSchema#string

Fernando Quevedo

http://www.w3.org/2001/XMLSchema#string

Graham H Bevan

http://www.w3.org/2001/XMLSchema#string

Liang Wang

http://www.w3.org/2001/XMLSchema#string

Lisa Boardman

http://www.w3.org/2001/XMLSchema#string

Manish Kohli

http://www.w3.org/2001/XMLSchema#string

Meihua Liang

http://www.w3.org/2001/XMLSchema#string

Meijun Du

http://www.w3.org/2001/XMLSchema#string

P2860

Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

Extracellular microRNAs in urologic malignancies: chances and challenges

Cancer statistics, 2013

Exosomes: a common pathway for a specialized function

Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper – Excel-based tool using pair-wise correlations

Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets

Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer

MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls.

eRNA: a graphic user interface-based tool optimized for large data analysis from high-throughput RNA sequencing.

Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease.

P304

33-41

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EURURO.2014.07.035

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

67

http://www.w3.org/2001/XMLSchema#string

P50

Rachel L Dittmar

P577

2014-08-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264726481

http://www.w3.org/2001/XMLSchema#string

P698

25129854

http://www.w3.org/2001/XMLSchema#string

P932

4252606

http://www.w3.org/2001/XMLSchema#string